Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Synergetics USA, Inc.

October 15, 2015

LAVAL, Quebec, Oct. 15, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that it has completed the previously announced acquisition of Synergetics USA, Inc. ("Synergetics").  Synergetics is a leading supplier of precision surgical devices. Synergetics' primary focus is on the surgical disciplines of ophthalmology and neurosurgery.  

About Valeant Pharmaceuticals International, Inc.

Valeant is a multinational, specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products and medical devices primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics.  More information about Valeant can be found at www.valeant.com.

Contact Information:

Laurie W. Little
949-461-6002
laurie.little@valeant.com

Elif McDonald
905-695-7607
elif.mcdonald@valeant.com

Valeant Pharmaceuticals International, Inc.

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-international-inc-completes-acquisition-of-synergetics-usa-inc-300160574.html

SOURCE Valeant Pharmaceuticals International, Inc.

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All